Completed NA INTERVENTIONAL 2-arm NCT01226563

IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction (PRESERVATION-1)

A Placebo Controlled, Multicenter, Randomized Double Blind Trial to Evaluate the Safety and Effectiveness of IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction

Sponsor: Bellerophon BCM LLC

Conditions Acute Myocardial Infarction Congestive Heart Failure ST-Elevation Myocardial Infarction

Interventions IK-5001 Saline Solution

Updated 11 times since 2017 Last updated: Feb 17, 2023 Started: Apr 30, 2012 Primary completion: Aug 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Acute Myocardial Infarction and Congestive Heart Failure, this trial is completed. The trial is conducted by Bellerophon BCM LLC and has accumulated 11 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2023 — Jul 2024 [monthly]

Completed NA
Sep 2022 — Mar 2023 [monthly]

Completed NA

▶ Show 6 earlier versions

Apr 2022 — Sep 2022 [monthly]

Completed NA
Jan 2021 — Apr 2022 [monthly]

Completed NA
Aug 2018 — Jan 2021 [monthly]

Completed NA

Phase: PHASE2 → NA
Jun 2018 — Aug 2018 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bellerophon BCM LLC

Data source: Bellerophon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Afula, Israel , Antwerp, Belgium , Ashkelon, Israel , Barcelona, Spain , Bedford Park, Australia , Berlin, Germany , Birmingham, United States , Brive-la-Gaillarde, France , Brussels, Belgium , Cincinnati, United States and 64 more locations